Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

CD4<sup>+</sup>CD25<sup>+</sup> regulatory T cells circumstantially initiate transplant rejection through CXCL15/neutrophil axis.

Communications biology·2026
Same author

High Humidity Exacerbates Psoriasiform Skin Disease Relapse by Increasing Tissue-Resident Memory T Cells via Altering Skin Microbiota.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same author

Corrigendum to "Defining Relationships Among Tests for Kidney Transplant Antibody-Mediated Rejection" [<i>Kidney International Reports</i> Volume 10, Issue 9, September 2025, Pages 3225-3238].

Kidney international reports·2026
Same author

Identification of a highly functional effector CD8<sup>+</sup> T cell program after transplantation in mice and humans.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2026
Same author

HEV-Targeted Antibody-Drug Conjugate Promotes Long-Term Cardiac Allograft Acceptance.

Circulation·2026
Same author

Stability and progressive differentiation of T<sub>FR</sub> cells are intrinsically and extrinsically controlled by T<sub>FH</sub> programs.

Nature immunology·2026

Related Experiment Video

Updated: Jun 11, 2026

In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients
18:48

In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients

Published on: August 12, 2017

Immunotherapy with myeloid cells for tolerance induction.

Mercedes Rodriguez-García1, Peter Boros, Jonathan S Bromberg

  • 1Immunología de Trasplantes, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Madrid, Spain.

Current Opinion in Organ Transplantation
|July 10, 2010
PubMed
Summary

Understanding how myeloid dendritic cells and T cells interact to promote transplantation tolerance is key. Specific conditions can generate tolerogenic dendritic cells and regulatory T cells (Tregs), aiding indefinite allograft survival.

More Related Videos

A Simple and Efficient Method for Testing Immunomodulatory Agents for Generation of Tolerogenic Dendritic Cells from Human CD14+ Monocytes
11:34

A Simple and Efficient Method for Testing Immunomodulatory Agents for Generation of Tolerogenic Dendritic Cells from Human CD14+ Monocytes

Published on: April 11, 2025

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

Related Experiment Videos

Last Updated: Jun 11, 2026

In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients
18:48

In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients

Published on: August 12, 2017

A Simple and Efficient Method for Testing Immunomodulatory Agents for Generation of Tolerogenic Dendritic Cells from Human CD14+ Monocytes
11:34

A Simple and Efficient Method for Testing Immunomodulatory Agents for Generation of Tolerogenic Dendritic Cells from Human CD14+ Monocytes

Published on: April 11, 2025

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

Area of Science:

  • Immunology
  • Transplantation Biology
  • Cellular Immunology

Background:

  • Myeloid dendritic cell-T-cell interactions are crucial for immune response outcomes.
  • Indefinite allograft survival is a major goal in transplantation.

Purpose of the Study:

  • To understand the interplay between myeloid dendritic cells and T cells under tolerogenic conditions.
  • To investigate if these interactions induce antigen-specific regulatory T cells (Tregs).
  • To uncover mechanisms promoting indefinite allograft survival.

Main Methods:

  • Review of in-vitro protocols for generating tolerogenic myeloid dendritic cells.
  • Analysis of T-cell modulation by these dendritic cells.
  • Assessment of adoptive transfer outcomes in allograft models.

Main Results:

  • Specific in-vitro protocols can generate tolerogenic myeloid dendritic cells.
  • These cells modulate T-cell responses and influence allograft outcomes.
  • Identifying conditions for tolerogenic dendritic cells and Tregs is critical for transplantation tolerance.

Conclusions:

  • Specific culture conditions generate tolerogenic myeloid dendritic cells that induce T-cell hyporesponsiveness and Treg development.
  • This represents a novel immunotherapeutic approach for indefinite graft survival.
  • Different mechanisms govern tolerogenic myeloid dendritic cell generation with therapeutic implications.